Racha Ghoussaini
YOU?
Author Swipe
View article: Ceftazidime-avibactam for the treatment of febrile neutropenia in HSCT recipients and acute leukemia patients post induction chemotherapy
Ceftazidime-avibactam for the treatment of febrile neutropenia in HSCT recipients and acute leukemia patients post induction chemotherapy Open
Febrile neutropenia is a major complication in patients with acute leukemia or those undergoing hematopoietic stem cell transplantation (HSCT). Understanding patient characteristics and susceptibility patterns in febrile neutropenia is ess…
View article: Ceftazidime-Avibactam for the Treatment of Febrile Neutropenia in HSCT Recipients and Acute Leukemia Patients Post Induction Chemotherapy
Ceftazidime-Avibactam for the Treatment of Febrile Neutropenia in HSCT Recipients and Acute Leukemia Patients Post Induction Chemotherapy Open
Background Febrile neutropenia is a common and major complication in patients with acute leukemia or those undergoing hematopoietic stem cell transplantation (HSCT). Understanding patient characteristics and patterns of susceptibility in f…
View article: Pulmonary artery banding: a 20-year experience at a tertiary care center in a developing country
Pulmonary artery banding: a 20-year experience at a tertiary care center in a developing country Open
Aim Pulmonary artery banding serves as an important palliative procedure used for the management of several congenital heart lesions. This study aims to describe a 20-year experience of pulmonary artery banding at a tertiary care center in…
View article: 2582. Real-World Analysis of the Outcomes of Patients Treated with Ceftazidime-Avibactam
2582. Real-World Analysis of the Outcomes of Patients Treated with Ceftazidime-Avibactam Open
Background Ceftazidime-avibactam (CAZAVI) is a novel β-lactam/β-lactamase inhibitor combination with activity against Pseudomonas aeruginosa and some carbapenem-resistant Enterobacterales. CAZAVI has been particularly useful as a carbapene…
View article: C-peptide is a predictor of telomere shortening: A five-year longitudinal study
C-peptide is a predictor of telomere shortening: A five-year longitudinal study Open
Aim Relative telomere length (RTL) predicts the development of many age-related diseases. Yet, few studies have evaluated their longitudinal effect on RTL. We investigated longitudinally the association between cardiometabolic risk factors…